Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;21(2):213-218.
doi: 10.2174/1570159X20666220927115811.

Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction

Affiliations

Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction

Laila Asth et al. Curr Neuropharmacol. 2023.

Abstract

Background: β-caryophyllene (BCP) is a natural bicyclic sesquiterpene found in Cannabis and other plants. BCP is currently used as a food additive, although pharmacological studies suggest its potential therapeutic application for the treatment of certain brain disorders. The mechanisms of action of BCP remain uncertain, possibly including full agonism at the cannabinoid CB2 receptor (CB2R).

Objective: The study aims to investigate BCP's potential as a new drug for the treatment of substance use disorders by reviewing preclinical studies with animal models.

Results: BCP has been investigated in behavioral paradigms, including drug self-administration, conditioned place preference, and intracranial self-stimulation; the drugs tested were cocaine, nicotine, alcohol, and methamphetamine. Remarkably, BCP prevented or reversed behavioral changes resulting from drug exposure. As expected, the mechanism of action entails CB2R activation, although this is unlikely to constitute the only molecular target to explain such effects. Another potential target is the peroxisome proliferator-activated receptor.

Conclusion: Preclinical studies have reported promising results with BCP in animal models of substance use disorders. Further research, including studies in humans, are warranted to establish its therapeutic potential and its mechanisms of action.

Keywords: Cannabinoids; Cannabis; abuse; addiction; drugs; β-caryophyllene.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest, financial or otherwise.

References

    1. Association A.P. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA. 2013 Available from: https://www.amberton.edu/media/Syllabi/Fall%202021/Graduate/CSL6798_E1.pdf.
    1. Wise R.A., Koob G.F. The development and maintenance of drug addiction. Neuropsychopharmacology. 2014;39(2):254–262. doi: 10.1038/npp.2013.261. - DOI - PMC - PubMed
    1. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005;8(11):1481–1489. doi: 10.1038/nn1579. - DOI - PubMed
    1. Koob G.F., Volkow N.D. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773. doi: 10.1016/S2215-0366(16)00104-8. - DOI - PMC - PubMed
    1. Koob G.F., Le Moal M. Addiction and the brain antireward system. Annu. Rev. Psychol. 2008;59(1):29–53. doi: 10.1146/annurev.psych.59.103006.093548. - DOI - PubMed